163 related articles for article (PubMed ID: 7178102)
1. [Use of the antikinin preparation prodectin in the complex treatment of pulmonary tuberculosis patients].
Keleberda KIa; Svistunova AS; Kaminskaia GO; Kordonskaia VM
Probl Tuberk; 1982 Oct; (10):42-5. PubMed ID: 7178102
[No Abstract] [Full Text] [Related]
2. [Use of prodectin in pulmonary tuberculosis].
Safarov RN; Makinskiĭ AI
Vrach Delo; 1981 Nov; (11):83-4. PubMed ID: 7342450
[No Abstract] [Full Text] [Related]
3. [Mechanism of action of the antikinin preparation pyridinolcarbamate on the development of experimental tuberculosis].
Makinskiĭ AI; Solov'eva IP; Braude VI
Probl Tuberk; 1984 May; (5):60-5. PubMed ID: 6739480
[No Abstract] [Full Text] [Related]
4. [Indications for using antikinin preparations and blood kinin system activators in the combined treatment of pulmonary tuberculosis].
Makinskiĭ AI
Probl Tuberk; 1981 Oct; (10):33-7. PubMed ID: 7312848
[No Abstract] [Full Text] [Related]
5. [Prodectin in the treatment of viral hepatitis].
Kozhukhova EA; Iakushin AI; Zakharova VI; Mebel' BD; Larionov GM
Sov Med; 1983; (10):96-7. PubMed ID: 6658556
[No Abstract] [Full Text] [Related]
6. [Effectiveness of pyridinolcarbamate in the overall treatment of infiltrative and cavernous-fibrous pulmonary tuberculosis].
Makinskiĭ AI; Safarov RN; Fondaminskaia LD; Semenova AS; Fedotova NN
Probl Tuberk; 1979 Jan; (1):26-30. PubMed ID: 368764
[No Abstract] [Full Text] [Related]
7. [Use of antikinin preparations as pathogenetic agents in the overall therapy of tuberculosis].
Makinskiĭ AI
Probl Tuberk; 1978 Apr; (4):70-4. PubMed ID: 349551
[No Abstract] [Full Text] [Related]
8. [Effect of prodectin on the activity of the blood kallikrein-kinin system in diffuse toxic goiter].
Oleĭnik VA; Matiashina GI
Probl Endokrinol (Mosk); 1986; 32(4):7-10. PubMed ID: 3639497
[TBL] [Abstract][Full Text] [Related]
9. [Changes of the blood kallikrein-kinin system in patients with diffuse toxic goiter under the influence of thyrostatic therapy and prodectin].
Matiashina GI
Vrach Delo; 1989 Apr; (4):31-3. PubMed ID: 2474220
[TBL] [Abstract][Full Text] [Related]
10. [Effect of parmidin on the course of tuberculosis under isoniazid therapy].
Solov'eva IP; Makinskiĭ AI
Vrach Delo; 1984 Sep; (9):70-3. PubMed ID: 6390963
[No Abstract] [Full Text] [Related]
11. [Plasma kinin system indices in diabetes mellitus patients before and after treatment with prodectin].
Spesivtseva VG; Men'shikov VV; Beliakov NV; Mamaeva GG; Stepanova NI
Probl Endokrinol (Mosk); 1978; 24(6):19-22. PubMed ID: 724671
[TBL] [Abstract][Full Text] [Related]
12. [Regulation of the activity of the blood kinin system as a method for the pathogenetic therapy of pulmonary tuberculosis].
Priĭmak AA; Makinskiĭ AI
Vrach Delo; 1985 Oct; (10):95-7. PubMed ID: 3841435
[No Abstract] [Full Text] [Related]
13. [Pathogenetic treatment of patients with disseminated neurodermatitis using the specific antikinin preparation parmidin].
Grebennikov VA
Sov Med; 1983; (1):44-7. PubMed ID: 6836389
[No Abstract] [Full Text] [Related]
14. [Effect of complamin and prodectin on microcirculation and lipid metabolism in psoriasis patients].
Rakhmatov AB; Bilash NV
Vestn Dermatol Venerol; 1983 Apr; (4):15-8. PubMed ID: 6868813
[No Abstract] [Full Text] [Related]
15. [Prodectin treatment of partial hearing loss as a result of atherosclerosis].
Smirnova NA; Timakov VA; Mikushkin MK
Vestn Otorinolaringol; 1982; (6):53-6. PubMed ID: 7179649
[No Abstract] [Full Text] [Related]
16. The use of prodectin in the treatment of cerebral arteriosclerosis and its complications.
Abrányi I; Máté
Ther Hung; 1976; 24(1):20-3. PubMed ID: 790631
[No Abstract] [Full Text] [Related]
17. Results obtained with prodectin in arteriosclerotic arterial obliteration of the lower extremities.
Hunyi L
Ther Hung; 1976; 24(2):67-71. PubMed ID: 982342
[No Abstract] [Full Text] [Related]
18. Clinical and laboratory examinations with Prodectin.
Bédi J; Kosztovics A; Pálos LA
Ther Hung; 1976; 24(3):91-7. PubMed ID: 1013926
[No Abstract] [Full Text] [Related]
19. Comparison of conservative (Prodectin) treatment and surgical intervention in arteriosclerotic obliterative diseases of the lower extremities.
Hunyi L
Ther Hung; 1978; 26(2):77-80. PubMed ID: 684660
[No Abstract] [Full Text] [Related]
20. [Activity of the kallikrein-kinin system in patients with ischemic heart disease treated with parmidine].
Vygovskiĭ VP; Zaremba EF; Podil'chak EM; Dutka RIa; Gorgota OV
Vrach Delo; 1985 Sep; (9):6-8. PubMed ID: 2416131
[No Abstract] [Full Text] [Related]
[Next] [New Search]
